PHI with Cerebral aplasia
How does this condition affect your private health insurance?
Gehirnaplasie, or cerebral aplasia, is a rare and severe congenital malformation characterized by the complete or significant absence of brain tissue. This devastating developmental anomaly occurs during early fetal development, often resulting from genetic factors, chromosomal abnormalities, or severe environmental insults. Infants born with Gehirnaplasie typically present with profound neurological deficits, including absence of cognitive function, motor control, and vital reflexes. The condition is incompatible with sustained life, and affected individuals rarely survive beyond the neonatal period or early infancy, making it a universally fatal diagnosis with no possibility of recovery or functional improvement.
PKV Risk Assessment
Individual, specialized PHI providers may still insure you, but with a significant surcharge.
Impact on Your Insurance Policy
Duration of Illness (Initial)
Present from conception; diagnosed prenatally or at birth.
Duration of Illness (Lifetime)
Lifelong, but typically very short (days to weeks) due to the condition's fatal nature.
Cost of Treatment (Initial)
High. Includes prenatal diagnostics (ultrasound, MRI), genetic counseling, delivery costs, and intensive neonatal palliative care or life support.
Cost of Treatment (Lifetime)
Very high for the short lifespan, primarily involving acute medical stabilization, pain management, respiratory support, and end-of-life palliative care.
Mortality Rate
Virtually 100%. The condition is incompatible with sustained life; survival beyond weeks or months is exceptionally rare.
Risk of Secondary Damages
100% severe neurological impairment, absent cognitive function, and total physical dependency, leading to rapid multi-organ failure.
Probability of Full Recovery
0%. As a structural absence of brain tissue, complete recovery is impossible.
Underlying Disease Risk
Moderate. Can be associated with other severe congenital anomalies or genetic syndromes, but often presents as an isolated, catastrophic central nervous system defect.